Your Money or Your Life - The High Cost of Cancer Drugs under Medicare Part D

N Engl J Med. 2022 Jun 9;386(23):2164-2167. doi: 10.1056/NEJMp2202726. Epub 2022 May 4.

Author

Stacie B Dusetzina¹

Affiliation

¹ From the Department of Health Policy, Vanderbilt University School of Medicine, and the Vanderbilt-Ingram Cancer Center - both in Nashville.

PMID: 35507526
DOI: 10.1056/NEJMp2202726

No abstract available

MeSH terms

Aged
Antineoplastic Agents* / economics
Antineoplastic Agents* / therapeutic use
Cost Sharing
Drug Costs*
Humans
Medicare Part D* / economics
Neoplasms* / drug therapy
Neoplasms* / economics
Prescription Drugs* / economics
United States

Substances

Antineoplastic Agents
Prescription Drugs